Matthew Gallagher grew up in motels and cars.

Last year, he built a $401 million company. Alone.
He launched Medvi in September 2024 with $20,000, no employees, and AI tools handling the code, the copy, the ads, and customer service.
By 2025, he had 250,000 customers, a 16.2% net margin, and $3 million coming in per day. For context, Hims & Hers runs a similar model with 2,442 employees and a 5.5% margin.
The story is real. So are the problems.
The FDA sent Medvi a warning letter citing deceptive product labeling, unauthorized equivalence claims between compounded and brand-name GLP-1 drugs, and inappropriate interstate distribution. Futurism reported AI-generated patient photos and deepfaked before-and-after images on the site.
Failure to fix the violations could lead to seizure or injunction.
None of that erases what Gallagher proved. It just adds the part most headlines left out.
AI can build the machine. It still can't read the warning label.